– Clinical state of increased glucocorticoids
– Most commonly due to corticosteroids therapy/adrenocorticotropic hormone (ACTH)
Etiology
- ACTH dependent
- Pituitary dependent – Cushings disease (65% cases)
- Synthetic ACTH
- ACTH tumours
- Non ACTH dependent
- Adrenal adenoma/carcinoma
- Complication of corticosteroid therapy
- Alcohol induced pseudo-cushings
Clinical features
- Pigmentation (ACTH only), hypokalemia, impaired glucose tolerance (frank diabetes), hypertension
- Signs and symptoms
Diagnosis
- Need to demonstrate inappropriate cortisol secretion – not supressed by exogenous steroids
- Dexamethasone suppression test – normal people supress levels to <50nmol/l (low dose 48h)
Differential diagnosis
- Plasma ACTH – <10nmol/l = non ACTH dependent
- Adrenal CT/MRI
- Serum potassium – hypokalemia (common ectopic ACTH secretion)
- CRH (corticotrophin releasing hormone ) test/ high dose dexamethasone test
- CXR – bronchial carcinoid
Treatment
- If untreated death from hypertension, AMI, heart failure
- Cortisol levels must be controlled before radiotherapy/surgery
- Trans-sphenoidal surgery, pituitary irradiation, bilateral adrenal irradiation
Drugs
- Metyrapone [1-4g/day q.i.d] (11B hydroxaylase inhibitor)
- Ketoconazole – [200mg t.i.d] (imidazole derivative, 17 alpha hydroxylase inhibitor)
- Decrease ACTH
- Bromocriptine, cabergoline, somatostatin analogues